Current Studies

The Division of Nephrology and Hypertension:

• Patrick Nachman , MD
  • A Phase III, Muti-Center, Double-Blind, Placebo-Controlled, Parallel-Arm Trial to Determine the Long Terms Safety and Efficacy of Oral Tolvaptan Tablet Regimens in Adult Subjects with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
  • A Randomized, Double-Blind, Placebo-Controlled, Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of FG-3019 in Subjects with Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy on Background ACEi or ARB Therapy